US6025346AExpiredUtility
1α-hydroxy vitamin D4 and novel intermediates and analogues
Est. expirySep 21, 2010(expired)· nominal 20-yr term from priority
A61K 8/606C07C 35/21A61Q 19/00A61K 8/67A61K 31/592A61K 31/59C07C 401/00
55
PatentIndex Score
16
Cited by
66
References
4
Claims
Abstract
Disclosed is 1 alpha ,24-dihydroxy vitamin D4 having the following structure: and pharmaceutical compositions containing said compound. The compound and composition are useful in the treatment of abnormal calcium metabolism. Also Disclosed is a method for the preparation of 1 alpha ,24-dihydroxy vitamin D4.
Claims
exact text as granted — not AI-modifiedWe claim:
1. 1α,24 dihydroxy vitamin D 4 .
2. A pharmaceutical composition, comprising an amount effective to increase serum calcium in a patient suffering Vitamin D deficiency of 1α,24 dihydroxy vitamin D 4 in combination with a pharmaceutically acceptable vehicle.
3. The pharamaceutical composition of claim 2, wherein said amount is administered orally.
4. 1α,24-dihydroxyvitamin D 4 produced in accordance with the method comprising incubating 1α-hydroxyvitamin D 4 with cultured human liver cells to form 1α,24-dihydroxyvitamin D 4 , and isolating and purifying the 1α,24-dihydroxyvitamin D 4 via high pressure liquid chromatography.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.